Patent: 7,135,305
✉ Email this page to a colleague
Summary for Patent: 7,135,305
| Title: | Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype |
| Abstract: | Methods for inhibiting lysis of coagulated blood and reducing risk of excessive lysis comprising administration of lysis-inhibiting amounts of apolipoprotein E4, and methods for inhibiting lysis of coagulated blood and reducing risk of excessive lysis comprising administration of a specific level of a lysis-inhibiting agent wherein the specific level is based on the apolipoprotein phenotype of an individual, are provided. Methods for enhancing lysis of coagulated blood by administration of an Apo E peptide fragment to blood containing a clot lysis agent are also provided. |
| Inventor(s): | Broderick; Joseph P. (Cincinnati, OH), Clark; Joseph F. (Cincinnati, OH), Woo; Daniel (Cincinnati, OH) |
| Assignee: | |
| Application Number: | 10/398,882 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,135,305
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Chiesi Usa, Inc. | RETAVASE | reteplase | For Injection | 103786 | 10/30/1996 | ⤷ Try a Trial | 2020-10-13 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
